-
Elutia to exhibit EluPro at Vizient technology exchange
-
Elutia Inc. (ELUT) Misses Q2 EPS by 7c
-
Elutia reports 49% sequential growth in EluPro revenue for Q2
-
Cantor Fitzgerald Reiterates Overweight Rating on Elutia (ELUT)
-
Elutia Inc. (ELUT) Tops Q1 EPS by 3c
-
Elutia (ELUT) Confirms No Material Impact from Global Tariffs
-
Elutia (ELUT) Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro
-
Cantor Fitzgerald newsletter says Elutia best, Anteris worst performer
-
Aziyo Biologics Inc. (ELUT) PT Maintained at $8 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Aziyo Biologics Inc. (ELUT)
-
Elutia Inc. (ELUT) Misses Q4 EPS by 2c, Misses on Revenue
-
Elutia (ELUT) Announces $15M Offering at $2.50/sh
-
Elutia (ELUT) Announces EluPro GPO Agreement with Southern Strategic Sourcing Partners
-
Elutia Inc. (ELUT) Tops Q3 EPS by 11c
-
SWK Holdings (SWKH) Provides Portfolio Update
-
SWK Holdings Provides Portfolio Update
-
Elutia Inc. (ELUT) Misses Q2 EPS by 78c
-
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
-
Aziyo Biologics Inc. (ELUT) PT Raised to $10 at Lake Street Capital Markets
-
Elutia (ELUT) Announces $13.26M Offering at $3.40/sh

